机译:海洋Omega-3脂肪酸摄入和阶段III结肠癌的存活,根据NCCTG期III试验N0147(联盟)的肿瘤分子标记
Harvard TH Chan Sch Publ Hlth Dept Epidemiol &
Nutr Boston MA USA;
Mayo Clin Alliance Stat &
Data Ctr Rochester MN USA;
Mayo Clin Alliance Stat &
Data Ctr Rochester MN USA;
Univ Leeds St Jamess Univ Hosp Leeds Inst Biomed &
Clin Sci Leeds W Yorkshire England;
Mayo Clin Alliance Stat &
Data Ctr Rochester MN USA;
Mayo Clin Dept Internal Med Div Gastroenterol &
Hepatol Rochester MN USA;
Mayo Clin Dept Oncol Rochester MN USA;
Mayo Clin Dept Internal Med Div Gastroenterol &
Hepatol Rochester MN USA;
Harvard TH Chan Sch Publ Hlth Dept Epidemiol &
Nutr Boston MA USA;
Univ Calif San Francisco Dept Epidemiol &
Biostat San Francisco CA 94143 USA;
Harvard Med Sch Boston MA 02115 USA;
Massachusetts Gen Hosp Clin &
Translat Epidemiol Unit Boston MA 02114 USA;
colorectal cancer; survivorship care; nutrition; inflammation; tumor microenvironment;
机译:海洋Omega-3脂肪酸摄入和阶段III结肠癌的存活,根据NCCTG期III试验N0147(联盟)的肿瘤分子标记
机译:III阶段结肠癌患者的身体活动和结果:III期试验NCCTG N0147(联盟)的相关分析
机译:大肠癌家族史及其对III期结肠癌切除患者生存的影响:NCCTG试验N0147(联盟)的结果
机译:澳洲小羊三角洲六种脂肪酸脱氢酶单核苷酸多态性分子标记与肌肉长链omega-3脂肪酸的遗传关联
机译:鱼摄入量,omega-3脂肪酸,汞和冠心病危险标志之间的关系(NHANES 1999--2002)。
机译:NCCTG N0147辅助化疗试验通过III期结肠癌的解剖肿瘤部位进行分子标记分析(联盟)
机译:海洋ω-3脂肪酸摄入和存活阶段III结肠癌根据NCCTG期III试验N0147(联盟)的肿瘤分子标记